Therapy News and Research

RSS

Women with breast cancer have less dermatitis when treated with intensity-modulated radiation therapy

All women treated with radiation therapy for breast cancer are at risk of developing dermatitis - a sometimes-painful skin condition caused by radiation as it makes its way through the skin to the tumor area and tissue within the breast.

28 Oct 2007

Walking prevents bone loss caused from prostate cancer treatment

Exercise may reduce, and even reverse, bone loss caused by hormone and radiation therapies used in the treatment of localized prostate cancer, thereby decreasing the potential risk of bone fractures and improving quality of life for these men, according to a study presented on October 28, 2007, at the American Society for Therapeutic Radiology and Oncology's 49th Annual Meeting in Los Angeles.

28 Oct 2007

Positioning pelvic cancer patients on stomachs for radiation yields better results

Oregon Health & Science University Cancer Institute researchers have found that positioning pelvic cancer patients on their stomachs rather than their backs is a better method for delivering radiation therapy.

28 Oct 2007

Surgery, radiation gives early survival advantage in bile duct cancer

Oregon Health & Science University researchers are reporting the discovery of an early survival advantage when a combination of surgery and radiation therapy is used for patients with a rare but deadly bile duct cancer.

28 Oct 2007

Therapeutic gene expression can be sustainable for 1 year

Researchers at the Board of Governors Gene Therapeutics Research Institute at Cedars-Sinai Medical Center have shown for the first time that it is possible to sustain therapeutic gene expression in the central nervous system for up to a year, even in the presence of an anti-viral immune response mechanism that is normally present in humans.

28 Oct 2007

Advancement in radiation oncology treatment called IMRT improves care, avoids healthy tissue

New advancements in a radiation oncology treatment called IMRT (intensity modulated radiation therapy) are proving far superior to standard radiation procedures used today in safeguarding the healthy tissues surrounding cancerous tumors, and thus improving patient care.

28 Oct 2007

Intravenous gene therapy protects normal tissue of mice during whole-body radiation

Gene therapy administered intravenously could be an effective agent to protect vital organs and tissues from the effects of ionizing radiation in the event of large-scale exposure from a radiological or nuclear bomb, according to an animal study presented today by University of Pittsburgh researchers at the 49th annual meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO) in Los Angeles.

28 Oct 2007

Integrated approach to IMRT provides quality care for head and neck cancer patients

Results from a University of Pittsburgh study demonstrate that intensity-modulated radiation therapy (IMRT) for head and neck cancer can be uniformly delivered in a large health care system of academic and community cancer centers through a centralized planning and treatment process.

28 Oct 2007

Highly targeted radiation therapy for prostate cancer prevents damage to surrounding organs

Oregon Health & Science University Cancer Institute researchers have found that highly targeted radiation therapy for prostate cancer can ensure that the majority of persons with this tumor will not have any long-term rectal damage.

28 Oct 2007

New model of HIV dynamics

The emergence of drug resistant forms of HIV often underlies the failure of current antiretroviral therapies for HIV infection.

28 Oct 2007

Education program leads to lasting improvement of cancer knowledge in African Americans

Disparities in access to health care and education hinder minorities and socioeconomically disadvantaged populations from receiving needed cancer services and often lead to delayed cancer diagnoses.

28 Oct 2007

Cancer patients not getting live-saving flu and pneumonia shots

Although flu and pneumonia can be lethal for cancer patients, more than one quarter of patients undergoing radiation therapy are not complying with national guidelines to be vaccinated against these potentially life-threatening yet preventable illnesses, according to a study presented October 28, 2007, at the American Society for Therapeutic Radiology and Oncology's 49th Annual Meeting in Los Angeles.

28 Oct 2007

FDA warns about 'stay awake drug' Provigil

The U.S. Food and Drug Administration (FDA) has issued a warning in connection with the drug Provigil because of dangerous side effects.

28 Oct 2007

Emerging cancer therapies and novel targets

What are the cancer drugs of tomorrow and how will they be developed? At the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, researchers will present some answers to these and other pressing questions regarding emerging cancer therapeutics.

25 Oct 2007

Blood markers can help choose best dose for antiangiogenic drugs

Scientists at Sunnybrook have new information that may help to improve the use of anti-cancer drugs designed to block the growth of new blood vessels in tumors, a process called angiogenesis that is critical to tumor growth.

25 Oct 2007

Medical College of Wisconsin receives grant to study infantile hemangiomas

The Food and Drug Administration (FDA) has awarded the Medical College of Wisconsin in Milwaukee a three-year, $1 million Orphan Products Development grant to study infantile hemangiomas – a vascular tumor of the skin or internal organs.

25 Oct 2007

Lower frequency deep brain stimulation effective treatment for dystonia

A Mount Sinai Medical Center study has found that lower frequency deep brain stimulation in young patients with primary torsion dystonia is as effective as higher frequency stimulation, which has been commonly used.

25 Oct 2007

Infliximab scheduled treatment has proven to be an effective strategy in IBD patients

Crohn's disease (CD) and ulcerative colitis (UC) are chronic-relapsing diseases, the clinical courses of which are characterized by periods of remission and periods of acute flare up, determining clinical symptoms which have a strong impact on the quality of life for patients.

25 Oct 2007

HIV patients are actually sicker when they begin therapy

It was hoped that as HIV treatment improved and as HIV-related public health initiatives encouraged people to be tested for the disease and seek care, that HIV-infected patients would seek care quickly.

25 Oct 2007

Researchers discover drug-craving brain region in rats

Chilean researchers have identified a region of the brain - the insular cortex - that plays a role in drug craving in amphetamine-addicted rats, according to a report published in the 26 October issue of the journal Science, published by the American Association for the Advancement of Science (AAAS), the nonprofit science society.

25 Oct 2007

Therapy News and Research

Women with breast cancer have less dermatitis when treated with intensity-modulated radiation therapy

Walking prevents bone loss caused from prostate cancer treatment

Positioning pelvic cancer patients on stomachs for radiation yields better results

Surgery, radiation gives early survival advantage in bile duct cancer

Therapeutic gene expression can be sustainable for 1 year

Advancement in radiation oncology treatment called IMRT improves care, avoids healthy tissue

Intravenous gene therapy protects normal tissue of mice during whole-body radiation

Integrated approach to IMRT provides quality care for head and neck cancer patients

Highly targeted radiation therapy for prostate cancer prevents damage to surrounding organs

New model of HIV dynamics

Education program leads to lasting improvement of cancer knowledge in African Americans

Cancer patients not getting live-saving flu and pneumonia shots

FDA warns about 'stay awake drug' Provigil

Emerging cancer therapies and novel targets

Blood markers can help choose best dose for antiangiogenic drugs

Medical College of Wisconsin receives grant to study infantile hemangiomas

Lower frequency deep brain stimulation effective treatment for dystonia

Infliximab scheduled treatment has proven to be an effective strategy in IBD patients

HIV patients are actually sicker when they begin therapy

Researchers discover drug-craving brain region in rats

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News